The Cleveland Orchestra’s recent performances of Beethoven’s “Fidelio” join concerts that fill a gap in American opera.

"We'll only be doing a few shows with this format," guitarist Carlos Chairez said of the band's upcoming dates. "We want everyone in Tijuana and San Diego to be able to see this." ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

«Al ser el primer biosimilar de pertuzumab, y actualmente el único, en Europa, la autorización de POHERDY por parte de la Comisión Europea supone un avance importante para ampliar el acceso a los ...

Sun Pharmaceutical Industries Ltd’s acquisition of Organon might yet avoid the pitfalls that its rivals, Lupin Ltd and Biocon Ltd, have faced in the past. Billed as among the largest deals in the ...

AI Quick Read Mumbai: Sun Pharma’s $11.75 billion acquisition of US-based Organon & Co. has pushed the Indian drugmaker into the global biosimilars market and and positions it among the top 10 players ...

Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (“Organon”) announced that they have entered into a definitive ...

Indian generic medicines giant Sun Pharmaceutical Industries is buying the women’s health company Organon in a deal worth $11.75 billion. The deal grants Sun Pharma, India’s largest pharmaceutical ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (junto con sus filiales y/o empresas vinculadas, “Sun Pharma”) y Organon & Co. (NYSE: OGN) ...

India's Sun Pharmaceutical on Monday said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. Sun Pharma will buy all of Organon's ...

Sun Pharma’s $11.75 billion all-cash deal to acquire global healthcare company, Organon is set to make the Indian pharma major the 7th largest global biosimilars player. The acquisition, likely to be ...